News
Medtronic (NYSE:MDT) announced that the FDA approved its Simplera Sync continuous glucose monitor for use with the.
The FDA clearance centers on the Layer 7 Cortical Interface, a wafer-thin, flexible electrode array designed to rest on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results